160 related articles for article (PubMed ID: 6640511)
1. Effect of quercetin on two-stage carcinogenesis of the rat urinary bladder.
Hirose M; Fukushima S; Sakata T; Inui M; Ito N
Cancer Lett; 1983 Nov; 21(1):23-7. PubMed ID: 6640511
[TBL] [Abstract][Full Text] [Related]
2. Promoting effect of sodium chloride in 2-stage urinary bladder carcinogenesis in rats initiated by N-butyl-N-(4-hydroxybutyl)nitrosamine.
Shibata MA; Nakanishi K; Shibata M; Masui T; Miyata Y; Ito N
Urol Res; 1986; 14(4):201-6. PubMed ID: 3787885
[TBL] [Abstract][Full Text] [Related]
3. Summation effect of uracil on the two-stage and multistage models of urinary bladder carcinogenesis in F344 rats initiated by N-butyl-N-(4-hydroxybutyl)nitrosamine.
Masui T; Shirai T; Takahashi S; Mutai M; Fukushima S
Carcinogenesis; 1988 Nov; 9(11):1981-5. PubMed ID: 3180336
[TBL] [Abstract][Full Text] [Related]
4. Promotion by ascorbic acid, sodium erythorbate and ethoxyquin of neoplastic lesions in rats initiated with N-butyl-N-(4-hydroxybutyl) nitrosamine.
Fukushima S; Kurata Y; Shibata M; Ikawa E; Ito N
Cancer Lett; 1984 May; 23(1):29-37. PubMed ID: 6744233
[TBL] [Abstract][Full Text] [Related]
5. Inhibitory effects of 1,3-diaminopropane, an ornithine decarboxylase inhibitor, on rat two-stage urinary bladder carcinogenesis initiated by N-butyl-N-(4-hydroxybutyl)nitrosamine.
Salim EI; Wanibuchi H; Morimura K; Kim S; Yano Y; Yamamoto S; Fukushima S
Carcinogenesis; 2000 Feb; 21(2):195-203. PubMed ID: 10657958
[TBL] [Abstract][Full Text] [Related]
6. Promoting effects of various chemicals in rat urinary bladder carcinogenesis initiated by N-nitroso-n-butyl-(4-hydroxybutyl)amine.
Fukushima S; Hagiwara A; Ogiso T; Shibata M; Ito N
Food Chem Toxicol; 1983 Feb; 21(1):59-68. PubMed ID: 6681793
[TBL] [Abstract][Full Text] [Related]
7. Promoting effects of various agents in rat urinary bladder carcinogenesis initiated by N-butyl-N-(4-hydroxybutyl)nitrosamine.
Kurata Y; Asamoto M; Hagiwara A; Masui T; Fukushima S
Cancer Lett; 1986 Aug; 32(2):125-35. PubMed ID: 3756839
[TBL] [Abstract][Full Text] [Related]
8. Lack of synergism in rat urinary tract carcinogenesis between prior uracil treatment and N-butyl-N-(4-hydroxybutyl)-nitrosamine administration.
Okumura M; Shirai T; Asamoto M; Ogiso T; Fukushima S
Cancer Lett; 1991 Jun; 58(1-2):81-5. PubMed ID: 2049787
[TBL] [Abstract][Full Text] [Related]
9. Lack of enhancing effect of two Kampo medicines, Sho-saiko-to (TJ-9) and Sairei-to (TJ-114), on rat urinary bladder carcinogenesis initiated with N-butyl-N-(4-hydroxybutyl)nitrosamine.
Hagiwara A; Sano M; Tanaka H; Kawabe M; Tamano S; Kadota T; Yanagisawa T; Maemura S; Ito N; Shirai T
Teratog Carcinog Mutagen; 2002; 22(1):41-50. PubMed ID: 11754386
[TBL] [Abstract][Full Text] [Related]
10. Effects of intravesical instillation of antitumor chemotherapeutic agents on bladder carcinogenesis in rats treated with N-butyl-N-(4-hydroxybutyl)nitrosamine.
Ohtani M; Fukushima S; Okamura T; Sakata T; Ito N; Koiso K; Niijima T
Cancer; 1984 Oct; 54(8):1525-9. PubMed ID: 6434176
[TBL] [Abstract][Full Text] [Related]
11. Effects of urinary potassium and sodium ion concentrations and pH on N-butyl-N-(4-hydroxybutyl)nitrosamine-induced urinary bladder carcinogenesis in rats.
Lina BA; Woutersen RA
Carcinogenesis; 1989 Sep; 10(9):1733-6. PubMed ID: 2548752
[TBL] [Abstract][Full Text] [Related]
12. Modification by alpha-tocopherol, propyl gallate and tertiary butylhydroquinone of urinary bladder carcinogenesis in Fischer 344 rats pretreated with N-butyl-N-(4-hydroxybutyl)nitrosamine.
Tamano S; Fukushima S; Shirai T; Hirose M; Ito N
Cancer Lett; 1987 Apr; 35(1):39-46. PubMed ID: 3567886
[TBL] [Abstract][Full Text] [Related]
13. Anti-promoting effect of nordihydroguaiaretic acid on N-butyl-N-(4-hydroxybutyl)nitrosamine and sodium saccharin-induced rat urinary bladder carcinogenesis.
Yu A; Hashimura T; Nishio Y; Kanamaru H; Fukuzawa S; Yoshida O
Jpn J Cancer Res; 1992 Sep; 83(9):944-8. PubMed ID: 1429204
[TBL] [Abstract][Full Text] [Related]
14. Pathological analysis of the carcinogenicity of sodium o-phenylphenate and o-phenylphenol.
Fukushima S; Kurata Y; Ogiso T; Okuda M; Miyata Y; Ito N
Oncology; 1985; 42(5):304-11. PubMed ID: 4034146
[TBL] [Abstract][Full Text] [Related]
15. Strain differences in N-butyl-N-(4-hydroxybutyl)nitrosamine bladder carcinogenesis in rats.
Nakanowatari J; Fukushima S; Imaida K; Ito N; Nagase S
Jpn J Cancer Res; 1988 Apr; 79(4):453-9. PubMed ID: 3133335
[TBL] [Abstract][Full Text] [Related]
16. Promotion by sodium L-ascorbate in rat two-stage urinary bladder carcinogenesis is dependent on the interval of administration.
Chen TX; Wanibuchi H; Murai T; Kitano M; Yamamoto S; Fukushima S
Jpn J Cancer Res; 1999 Jan; 90(1):16-22. PubMed ID: 10076560
[TBL] [Abstract][Full Text] [Related]
17. Summation effects of uracil and other promoters on epithelial lesion development in the F344 rat urinary bladder initiated by N-butyl-N-(4-hydroxybutyl)nitrosamine.
de Camargo JL; Shirai T; Kato T; Asamoto M; Fukushima S
Jpn J Cancer Res; 1991 Nov; 82(11):1220-5. PubMed ID: 1752781
[TBL] [Abstract][Full Text] [Related]
18. Combined effects of L-ascorbic acid, citric acid or their sodium salts on tumor induction by N-butyl-N-(4-hydroxybutyl)nitrosamine or N-ethyl-N-(4-hydroxybutyl)nitrosamine in the rat urinary bladder.
Inoue T; Imaida K; Suzuki E; Okada M; Fukushima S
Cancer Lett; 1988 Jun; 40(3):265-73. PubMed ID: 3383181
[TBL] [Abstract][Full Text] [Related]
19. Trisodium nitriloacetate monohydrate: promoting effect in urinary bladder carcinogenesis in rats treated with N-butyl-N-(4-hydroxybutyl)nitrosamine.
Hiasa Y; Kitahori Y; Konishi N; Shimoyama T; Miyashiro A
J Natl Cancer Inst; 1985 Jan; 74(1):235-9. PubMed ID: 3855482
[TBL] [Abstract][Full Text] [Related]
20. Patterns of epithelial proliferation revealed by continuous administration of bromodeoxyuridine during urinary bladder carcinogenesis in rats.
Tatematsu M; Fukushima S; Aoki T; Mera Y; Inoue T; Ito N
Jpn J Cancer Res; 1987 Sep; 78(9):879-82. PubMed ID: 3117745
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
